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Summary
Transcytolemal water exchange and its effect on myo-
cardial T1 relaxation can, if neglected, lead to a signifi-
cant underestimate of the myocardial extracellular
volume fraction, a novel marker of diffuse fibrosis.
Background
LGE may fail to detect diffuse fibrosis in several cardiac
conditions. A novel approach uses the myocardial extra-
cellular volume-fraction (MECVF), measured as distribu-
tion volume of a gadolinium constrast, as a marker of
extracellular expansion. Previous studies have assumed the
fast-exchange (FX) limit for the transcytolemal water-
exchange, yet the administration of an extracellular-agent
can create significant transcytolemal T1-differences, and
cause an underestimation of extracellular volume fraction
under the FX assumption. We hypothesized that the quan-
titative measure of MECVF with using a 2-site H-exchange
model (2SX-model) correlates positively with the extracel-
lular volume fraction, while the FX approach underesti-
mates extra-cellular matrix expansion in a rodent model
of hypertensive heart disease and diffuse myocardial fibro-
sis created by administration of L-NAME.
Methods
L-NAME(3mg/ml) or placebo was administered respec-
tively to 22(bw=36.9±2.3g) and 15(bw=37.6±2.5g) wild-
type mice. Animals were imaged at baseline and 7-
weeks after treatment on a 4.7T small-animal MRI-sys-
tem. T1(#of T1’s>5/mouse) was quantified with a
modified Look-Locker gradient-echo-cine technique,
before and after fractionated Gd-DPTA administration
(mean max. R1 in blood post-contrast=5.0±2.26 1/s).
MECVF obtained from the T1 measurements with the
2SX and FX-models, and by using blood hematocrit to
adjust the partition coefficient. Connective tissue volume
fraction (CTVF) was measured using Masson’s
trichrome.
Results
L-NAME-treated animals demonstrated hypertrophy
(weight-indexed LVmass 4.1±0.4 vs. 2.2±0.3 μg/g,
p<0.001) and increased CTVF (8.6%±1.5 vs. 2.58%±0.6,
P<0.001) as compared to controls. MECVF was substan-
tially higher in L-NAME-treated animals (0.43±0.09 vs,
0.26±0.03, p<0.001 with 2SX-model; 0.20±0.03 vs. 0.20
±0.05, p=0.82 without TWE with FX assumption).
MECVF from 2SX-model showed a good correlation
with CTVF and weight-indexed LVmass (both r=0.8,
p<0.0001), while MECVF from FX-model did not corre-
late significantly with CTVF(p=0.44) and LVmass
(p=0.80)(fig-1). MECVF from the 2SX model also corre-
lated with the LVEF at 7-weeks(r=0.48, p=0.01). Bland-
Altman analysis demonstrated that neglect of the trans-
cytolemal water exchange causes a significant underesti-
mate MECVF expansion(fig-2), which worsens with
extracellular matrix expansion and LVH.
Conclusions
CMR MECVF quantification provides a robust measure of
myocardial extracellular matrix expansion and interstitial
fibrosis, though any break-down of the FX assumption for
transcytolemmal exchange can result in a significant
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of MECVF due to the FX assumption depend on the
degree of cell-hypertrophy, and the maximum T1 in the
blood pool. A break-down of the FX assumption cannot
be detected with protocols limited to a pair of pre/post-
contrast T1 measurements. A generalization of the model
for determination of MECVF brings important benefits for
an early detection of diffuse fibrosis.
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Figure 1 Correlation: MECVF (2-site H-exchange and Fast-exchange) and connective tissue volume fraction
Figure 2 Bland-Altman analysis
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